A just released book, "Invisible Killers: The Truth About Environmental Genocide" by
Rik Deitsch and
Stewart Lonky, M.D., is getting national attention for providing valuable information about the myriad of toxins that humans are exposed to and the measures that can be taken to minimize their effects.
Deitsch and Lonky begin the book by stating that "it is not our intent to frighten this audience into believing that Armageddon is at hand from a hopelessly polluted environment, but we also do not intend to diminish the real dangers that do exist."
Concentrating primarily on the toxins in the air, water, food and in the home, Invisible Killers goes through toxic threats, both natural and man-made, with a style that informs and educates in common sense language for readers of all backgrounds. In Part I they go through the threats by identifying the compound, naming the source of exposure, and finally cataloging the possible health effects from that particular toxin. Part II, with chapters like Methods of Detoxification, Deitsch and Lonky catalog a number of methods and cures for exposure.
They also give the reader a premier of how the body deals with the various compounds, serving to give one a look at bodily functions that could prove invaluable in a variety of other situations. "Invisible Killers: The Truth About Environmental Genocide" is a must read for all concerned about the environment and the health of family and friends.
Dr. Lonky is board certified in internal medicine, pulmonary and critical care medicine. As a National Institutes of Health post doctoral fellow and as a full-time faculty member at the University of California, San Diego he spearheaded a research team studying the cellular and biochemical mechanisms of lung injury. His practice involves the evaluation and treatment of patients with toxic exposures as well as patients with lung disease.
In addition, he has served as the Chief Medical Officer for a diagnostic device company that developed technologies for the early diagnosis of certain epithelial cancers. His practice is located in Los Angeles, California.
Rik Deitsch, Chief Executive Officer of Nutra Pharma Corp. (nutrapharma.com), served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted research for the Duke University Medical School Comprehensive Cancer Center.
He is an adjunct professor and teaches several courses for Florida Atlantic University's College of Business and Continuing Education Department.
For media interviews contact Promotion in Motion at (323) 461-3921 or brad@promotioninmotion.net